Introduction. To develop an international guideline (AOGO) about use of osteobiologics in
Aims. Whether to perform hybrid surgery (HS) in contrast to
Study design: Retrospective review of patients with cervical spondylosis treated with three-level
Introduction: Although
Background. The controversy concerning the benefits of unisegmental cervical disc arthroplasty (CDA) over
1. A series of 154 patients who underwent
We retrospectively reviewed the results of patients having undergone single or two level
This study was performed to evaluate the clinical and radiographic outcomes in patients undergoing
Aim: To determine the clinical improvement and the radiological time to fusion as well as correction of the lordosis angle in patients undergoing anterior cervical interbody fusion with the use of a silicate substituted calcium phosphate ceramic (Si-CaP) (Actifuse™ Synthetic Bone Graft, ApaTech, Ltd., Elstree, UK) as the bone graft substitute in the cage. Design: We conducted a prospective clinical and radiological study to evaluate the use of Si-CaP as bone graft substitute in anterior cervical fusion for degenerative cervical spondylosis. Materials and methods: Thirty patients were selected prospectively by preoperative and postoperative clinical and radiological assessments. All patients were operated on by a single surgeon (D.A.J.). Neck disability index and visual analogue score were used for the clinical assessment. Radiological assessment included improvement in the lordosis angle and time to fusion. Patients were evaluated at three months, six months and one year post-surgery. Results: At present 14 patients with a total of 19 levels have completed their one year follow-up. The patients had an average of 50.4 years (range 34–69), with ratio of male to female of 6:7. Lordosis angle improved significantly from a mean lordosis angle of 0.31 preoperatively to 4.75 degree postoperatively (p<
0.05). All the levels had fused at the 1 year follow up and there was no radiological evidence of sinkage of the cage. Conclusion: Substitution of silicate ions into calcium phosphate ceramics has been shown to impart a negative surface charge, leading to greater protein absorption, increased osteoblast proliferation, and higher production of extracellular matrix. Our results show that Si-CaP has excellent clinical performance as a synthetic bone graft in
The December 2022 Spine Roundup. 360. looks at: Deep venous thrombosis prophylaxis protocol on a Level 1 trauma centre patient database; Non-specific spondylodiscitis: a new perspective for surgical treatment; Disc degeneration could be recovered after chemonucleolysis; Three-level
The October 2024 Spine Roundup. 360. looks at: Analysis of risk factors for non-fusion of bone graft in
Aims. In order to evaluate the effectiveness of the Mobi-C implant
in cervical disc degeneration, a randomised study was conducted,
comparing the Mobi-C prosthesis arthroplasty with anterior cervical
disc fusion (ACDF) in patients with single level cervical spondylosis. Patients and Methods. From January 2008 to July 2009, 99 patients were enrolled and
randomly divided into two groups, those having a Mobi-C implant
(n = 51; 30 men, 21 women) and those undergoing ACDF (n = 48; 28
men, 20 women).The patients were followed up for five years, with
the primary outcomes being the Japanese Orthopaedic Association
score, visual analogue scale for pain and the incidence of further
surgery. The secondary outcomes were the Neck Disability Index and
range of movement (ROM) of the treated segment. Results. The incidence of further surgery was found to be statistically
significant between the two groups (p = 0.49), with seven ACDF patients
requiring further surgery and only one Mobi-C patient requiring
re-operation. There were significant differences (p <
0.001)
between the two groups in the ROM of the treated segment. However,
both Mobi-C surgery and
Abstract. Objectives. There is still controversy in the literature over whether Cervical Foraminotomy or
AO Spine Guideline for Using Osteobiologics in Spine Degeneration project is an international collaborative initiative to identify and evaluate evidence on existing use of osteobiologics in spine degenerative diseases. It aims to formulate clinically relevant and internationally applicable guidelines ensuring evidence-based, safe and effective use of osteobiologics. The current focus is the use of osteobiologics in
Objectives. Pulsed electromagnetic field (PEMF) stimulation was evaluated after
The August 2015 Spine Roundup360 looks at: Steroids may be useful in avoiding dysphagia in